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Abstract
Background: Heteroplasmic mitochondrial 3697G>A mutation has been associated
with leber hereditary optic neuropathy (LHON), mitochondrial encephalopathy, lactic acidosis and stroke‐like episodes (MELAS), and LHON/MELAS overlap syndrome. However, homoplasmic m.3697G>A mutation was only found in a family
with Leigh syndrome, and the phenotype and pathogenicity of this homoplasmic
mutation still need to be investigated in new patients.
Methods: The clinical interviews were conducted in 12 individuals from a multiple‐
generation inherited family. Mutations were screened through exome next‐generation sequencing and subsequently confirmed by PCR‐restriction fragment length
polymorphism. Mitochondrial complex activities and ATP production rate were
measured by biochemical analysis.
Results: The male offspring with bilateral striatal necrosis (BSN) were characterized
by severe spastic dystonia and complete penetrance, while the female offspring presented with mild symptom and low penetrance. All offspring carried homoplasmic
mutation of NC_012920.1: m.3697G>A, p.(Gly131Ser). Biochemical analysis revealed an isolated defect of complex I, but the magnitude of the defect was higher in
the male patients than that in the female ones. The ATP production rate also exhibited a similar pattern. However, no possible modifier genes on the X chromosome
were identified.
Conclusion: Homoplasmic m.3697G>A mutation could be associated with BSN,
which expanded the clinical spectrum of m.3697G>A. Our preliminary investigations had not found the underlying modifiers to support the double hit hypothesis,
while the high level of estrogens in the female patients might exert a potential compensatory effect on mutant cell metabolism.
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bilateral striatal necrosis, homoplasmy, mitochondrial DNA mutation, sex bias

*The authors had equal contribution to this work.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original
work is properly cited.
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Mol Genet Genomic Med. 2019;7:e541.		
https://doi.org/10.1002/mgg3.541

wileyonlinelibrary.com/journal/mgg3

|

1 of 9

|

2 of 9

1

  

|

IN TRO D U C T ION

Bilateral striatal necrosis (BSN) is a heterogeneous group of
neurodegenerative diseases named after the distinctive neuroradiological features (Lim, 2009). The main neurological
findings are characterized by symmetrical degeneration of
putamen, caudate nucleus, and globus pallidus occasionally.
The pathogenesis of BSN is heterogeneous and has been associated with various acquired and hereditary causes (Chokshi,
Aygun, & Mullins, 2014). Hereditary striatal degeneration can
be inherited as an autosomal dominant, autosomal recessive, or
mitochondrial disorder (Tonduti et al., 2016). Adult‐onset autosomal‐dominant BSN is caused by mutations in the phosphodiesterase 8B (PDE8B, OMIM #603390) gene on chromosome
5q13 (Appenzeller et al., 2010). Autosomal‐recessive BSNs are
associated with mutations in several genes such as solute carrier
family 25 member 19 (SLC25A19, OMIM #606521) (Spiegel
et al., 2009), nucleoporin 62 (NUP62, OMIM #605815)
(Bianciardi et al., 2016), adenosine deaminase RNA specific
(ADAR1, OMIM: 146920) (La Piana et al., 2014), and protein
Vac14 homolog (VAC14, OMIM #604632) (Stutterd et al.,
2017). Mitochondrial BSNs are caused by mutations in both mitochondrial and nuclear genes associated with the maintenance
of mitochondrial function (Binder et al., 2003; Thyagarajan,
Shanske, Vazquez‐Memije, Vivo, & DiMauro, 1995).
Several mitochondrial DNA (mtDNA) mutations associated with defects of oxidative respiratory chain enzymes were
linked with infantile‐onset BSNs (Hirayanagi et al., 2017;
Tarnopolsky, Meaney, Robinson, Sheldon, & Boles, 2013).
The heteroplasmic mutation of NC_012920.1: m.3697G>A,
p.(Gly131Ser) in the mitochondrial NADH dehydrogenase
subunit 1 (MTND1, OMIM #516000) gene was identified in
patients with mitochondrial encephalomyopathy, lactic acidosis and stroke‐like episodes (MELAS) (Kirby et al., 2004),
Leber's hereditary optic neuropathy (LHON) (Spruijt et al.,
2007), LHON/MELAS overlap syndrome (Blakely et al.,
2005), and Stüve‐Wiedemann syndrome (Morava, Hamel, Hol,
Rodenburg, & Smeitink, 2006). In contrast, the homoplasmic m.3697G>A mutation was found as a causation of Leigh
syndrome (LS) in a Japanese family (Negishi et al., 2014), in
which the affected individuals exhibited early childhood‐onset
rigidity of the upper and lower limbs due to bilateral basal
ganglion and brainstem degeneration. Herein, we investigated
the clinical features, brain MRI changes, genetic findings, and
mitochondrial function in a family with BSN and assessed its
association with homoplasmic m.3697G>A mutation.
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provided by every examined individual according to the
Declaration of Helsinki. The study was approved by the
institutional ethical review board of the Peking University
People's Hospital.

2.2

|

Patients

The index patient was a 20‐year‐old man (III3) from a nonconsanguineous family (Figure 1). He had rigidity on the left
limbs since he was 6 years old. The dystonia insidiously progressed and resulted in clumsy movements of the left limbs,
but the symptoms maintained a stable condition since the age
of eight. Eight months ago, the right limbs started exhibiting
similar rigidity. He presented with dysarthria, dysphagia, and
difficulty of standing steadily. The patient had no complaints
about muscle weakness, myalgia, or numbness. Mini‐mental
state examination (MMSE) revealed a moderate cognitive
disability (17/30). Physical examination revealed scoliosis,
finger joint contracture, left ankle deformity, and an increased muscle tone of the neck and all of the limbs. Muscle
strength graded 5/5 in the right limbs and 4/5 in the left limbs
(Medical Research Council Scale). The deep tendon reflexes
of the lower limbs were enhanced. The Babinski sign was
positive on the left side. His visual acuity and auditory ability
were unimpaired. The pinprick, position, and vibration sensations were normal.
The elder aunt's son (III2) was 23 years old, and he displayed spastic gait at the age of five. He developed upper limb
spasticity, lower limb tightness, and walking difficulty at the
age of 10. He was wheelchair‐bound when he was referred
to our clinic at the age of 26. His cognitive performance was
mildly decreased (MMSE: 20/30). Physical examination revealed enhanced muscle tone. The sensations were intact, and
the optic neuropathy was not detected.
The index patient's young brother (III5) was 16 years
old. He had similar symptoms with the index patient. The
age of onset was four. Clinical symptoms included moderate cognitive ability (MMSE: 17/30), scoliosis, finger joint

M AT E R IA L S A N D ME T HODS

|

Ethical compliance

The clinical examinations and genetic analyses in this family were conducted after the written informed consent was

F I G U R E 1 The pedigree of family: squares, male; circles,
female; black symbols, affected; arrow, the index
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contracture, deformity of the ankle joint, and enhanced muscle tone. No sensations or optic nerves were impaired.
The mother (II4) was 47 years old and started having
slight clumsiness of left upper limbs at the age of 18, but
the symptoms had been stable since she was 20 years old.
Physical examination revealed an enhanced muscle tone on
the left upper limbs. No other abnormalities were detected.
The elder aunt (II1) was reported to have clumsy movement of right limbs since 17 years old, and the symptoms
had not progressed since she was 20 years old. The grandmother (I1) had rigid hands in her 20 s, but quickly became
progression‐free. The young aunt (II6) had no complaints of
any symptoms, but her son (III7) had a similar clumsy gait as
that of the index patient and died of severe injury at age 17.
The detailed data were summarized in Table 1. The family
individuals (III1, III4, III6, III8, and III9) were not found to
have any symptoms or abnormal signs.

2.3

|

Brain MRI

Brain MRI was conducted by a 3.0‐T MR scanner
(Seimen). Conventional T1‐weighted spin echo (T1WI)
sequences were obtained with the following parameters:
repetition time (TR) = 250 ms, echo time (TE) = 2.5 ms,
FoV = 306 × 220 mm; conventional T2‐weighted spin
echo (T2WI) sequences: TR = 4,000 ms, TE = 157 ms,
TABLE 1

|
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FoV = 306 × 220 mm; fluid‐attenuated inversion recovery (FLAIR) sequences: TR = 8,000 mm, TE = 79 mm,
FoV = 306 × 220 mm; diffusion tensor imaging (DTI):
TR = 7,700 mm, TE = 104 mm, FoV = 315 × 227 mm;
magnetic resonance spectroscopy (MRS): TR = 1,900 mm,
TE = 2.3 mm, FoV = 695 × 500 mm. The slice thickness
was 5 mm, and the slice gap was 6.5 mm.

2.4

|

Mutation analysis

Genomic DNA was extracted from peripheral blood samples
of family members II4, III3, and III4. Initially, the genetic
test was conducted through exome next‐generation sequencing (NGS). Targeted exon enrichment was performed using
SureSelect Human All Exon V4 (Agilent Technologies,
Santa Clara, CA, USA). The exon‐enriched DNA libraries
were subjected to paired‐end sequencing with the Hiseq2000
platform (Illumina, Inc., San Diego, CA, USA). Calls with
variant quality <20 were filtered out, and 95% of the targeted
bases were covered sufficiently to pass our thresholds for
calling single‐nucleotide polymorphisms (SNP) and small
insertions or deletions.
Whole mtDNA sequencing was conducted after long‐PCR
amplification. Amplified fragment was directly sequenced
using a BigDye ready reaction kit (Applied Biosystems,
Foster City, CA, USA) and was run on an ABI 3700 automated

The clinical features and the laboratory findings in the BSN family with homoplasmic m.3697G>A

Patient

Age/gender

Age at onset

I1

73/F

20

II1

50/F

II4

Clinical
features

Optic symptoms

MMSE

Cerebral MRI

Mutation

Hands
rigidity

None

24

NA

NA

17

Right
limbs
clumsy

None

30

Left hyperintensities
of the putamen

Homoplasmic m.3697G>A

47/F

18

Left limb
rigidity

None

29

Right hyperintensities
of the putamen

Homoplasmic m.3697G>A

II6

44/F

NA

None

None

30

Normal

Homoplasmic m.3697G>A

III1

25/F

NA

None

None

30

Normal

Homoplasmic m.3697G>A

III2

23/M

5

Spastic
dystonia

None

20

Bilateral hyperintensities of the putamen

Homoplasmic m.3697G>A

III3

20/M

6

Spastic
dystonia

None

17

Bilateral hyperintensities of the putamen

Homoplasmic m.3697G>A

III4

18/F

NA

None

None

30

Normal

Homoplasmic m.3697G>A

III5

16/M

4

Spastic
dystonia

None

17

Bilateral hyperintensities of the putamen
and caudate nucleus

Homoplasmic m.3697G>A

III6

9/F

NA

None

None

27

Normal

Homoplasmic m.3697G>A

III7

17a/M

5

Spastic
dystonia

NA

NA

Bilateral hyperintensities of the putamen

NA

Notes. F: female; M: male; MMSE: mini‐mental state examination; NA: unavailable.
a
The patient died at the age of 17.
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sequencer (Applied Biosystems). Identical mtDNA fragment
from the family members (II1, II4, II6, III1, III2, III4, III5,
and III6) was examined for the presence of the mutation.
In order to detect the mutant load of m.3697G>A, NGS
targeted to MitoExome was performed using the blood and
urine sediments of the index patient (III3) and the blood of
member II4, III5, III6 (PrecisionMD Technology, Beijing,
China). The average depth of reads for single nucleotide
reached over 5,000 times, enabling the detection of heteroplasmic variants at levels of <0.1%. In addition, mutant load
of m.3697G>A was further assessed by PCR‐restriction
fragment length polymorphism (PCR‐RFLP). The mtDNA
fragments were initially amplified using the primers as
follows: forward 5′‐TACTTCACAAAGCGCCTTCC‐3′
and reverse 5′‐ATGAAGAATAGGGCGAAGGG‐3′, then
cleaved by BclI restriction endonuclease (NEB, Ipswich,
MA, USA), and finally separated by electrophoresis. The
intensity of the bands was quantified by Gel‐Pro Analyzer
4.0 (MediaCybernetics, Warrendale, PA, USA). GenBank
NC_012920.1 was adopted as the reference sequence.
The mtDNA sequence of the index patient carrying
the m.3697G>A mutation was initially analyzed through
MitoTool software (www.mitotool.org/) and then assigned to
the Asian mitochondrial haplogroups by using the nomenclature of mitochondrial haplogroups (Tanaka et al., 2004).

|

2.5

Biochemical analysis

B‐lymphocytes from several family individuals (II4, III3,
III5, and III6) were immortalized as described previously
(Hammerschmidt & Sugden, 1989). Individual oxidative
phosphorylation system (OXPHOS) complexes were extracted from mitochondria using n‐dodecyl‐β‐d‐maltoside
(Sigma, St Louis, MO, USA) with a detergent/protein ratio
of 2.5 g/g. Proteins (60 μg) containing 0.5% Blue G‐250
(Sigma) and 5% glycerol were separated via electrophoresis
on 3%–11% gradient blue native polyacrylamide gels as previously described (Xu et al., 2017).
ATP production rate was assessed using an ATP measurement kit (Molecular Probes, Carlsbad, CA, USA) according to the manufacturer's instructions. To measure
mitochondrial ATP level, cells were incubated with 10 mM
glucose (Sigma) or 5 mM 2‐DG with 5 mM pyruvate for
2 hr prior to the measurement. Fluorescence/luminescence was measured using a VarioskanTM Flash Multimode
Reader (Thermo Fisher Scientific, Waltham, MA, USA).

3
3.1

|

R ES U LTS
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Brain MRI features

Brain MRI of the index patient displayed high signal intensities in the bilateral putamen on T2WI and mildly high signal

ZHONG et al.

intensities on FLAIR images (Figure 2; III3). Abnormal signals in the bilateral putamen were also observed in the images
of all other affected male individuals (Figure 2; III2, III5,
and III7). In addition, high‐intensity signals in the bilateral
caudate nucleus were observed in the images of patient III5
(Figure 2; III5). The elder aunt (II1) only had a high‐intensity
signal in the left putamen (Figure 2; II1), and the mother (II4)
had high‐intensity signal only in the right putamen (Figure 2;
II4). In contrast to the male individuals, the female patient II6
(at age 45), patient III1 (at age 29), patient III4 (at age 18),
and patient III6 (at age 9) had normal brain MRI images. The
signal intensities were negatively related to enhancement in
the lesions, but the lesions showed the fiber interruption on
DTI images and severe decrease of n‐acetylaspartate (NAA)
on MRS measure (Supporting Figure S1).

3.2

|

Mitochondrial DNA mutation

The homoplasmic mutation of NC_012920.1: m.3697G>A,
p.(Gly131Ser) was detected in the index patient (III3) through
mtDNA Sanger sequence (Figure 3a), which changes a very
evolutionarily conserved glycine into serine at 131 amino acid
of MTND1 (p.Gly131Ser; Figure 3b). The same homoplasmic
mutation was identified in the circulating lymphocytes from the
available family individuals (II1, II3, II4, II6, III1, III2, III4, III5,
and III6). Targeted NGS for MitoExome showed that the index
patient had more than 99.9% of m.3697G>A mutation in the
circulating lymphocytes, and more than 99.9% of m.3697G>A
mutation in the urinary epithelium; the mother (II4) had more
than 99.9% of m.3697G>A mutation in the circulating lymphocytes; and the asymptomatic sister (III4) had more than 99.9% of
m.3697G>A mutation in the circulating lymphocytes (Table 2).
In the PCR‐RFLP analysis, the wild‐type MTND1 fragment would be cleaved into two small fragments of 532 bp
and 300 bp, while the mutant MTND1 fragment would be cut
into three small fragments of 532 bp, 270 bp, and 30 bp. The
PCR‐RFLP showed that no 300 bp fragment was detected in
the samples from patient II4, III3, III4, and III5, which indicated that the mutant loads of m.3697G>A were 100% in
these patients (Figure 3c).
From the whole mtDNA sequencing of the blood from
the index patient, the following polymorphisms were found:
m.709T>C, m.3759A>G, m.5153A>G, m.5178C>T,
m.9180A>G, m.10397A>G, m.15724A>G, m.16189T>C,
and m.16519T>C. The results indicated that this family belonged to the mitochondrial haplogroup D5b1b, which was
commonly found in Japan and North China. This haplogroup
had been reported to be associated with schizophrenia,
Parkinson disease, and diabetes in Japanese population, but
had not been linked to BSN, LS, or LHON. Except for the
homoplasmic mutation m.3028A>T, all the other polymorphisms were known as variations of the Cambridge sequence
(Supporting Information Table S1).

ZHONG et al.
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FIGURE 2

Brain MRI findings of
family individuals. Magnetic resonance
images of patients showed high‐intensity
signals in the bilateral putaminal areas on
both T2‐weighted (T2) and fluid‐attenuated
inversion recovery (FLAIR) images in male
patients III2, III3, III5, and III7; unilateral
putaminal areas in female patients II1 and
II4; and normal cerebral structure in other
female individuals II6, III1, III4, and III6

F I G U R E 3 The homoplasmic mutation of NC_012920.1: m.3697G>A, p.(Gly131Ser) was found in the index patient (III3), his mother
(II4), and his sister (III4), but not his father (II3) (a). The mutation changes a very evolutionarily conserved glycine into serine at 131 amino acid of
MTND1 (b). The homoplasmy of m.3697G>A mutation was confirmed by PCR‐RFLP. The wild‐type fragment will be cleaved into two fragments
of 532 bp and 300 bp, while the mutant fragment will be cut into three fragments of 532 bp, 270 bp, and 30 bp (c)

6 of 9
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TABLE 2

The targeted next‐generation sequencing for mitochondrial DNA in the index patient (III3), his mother (II4), and his younger sister

(III4)

Sample

Read G (wt)

Read A

Read C

Read T

Heteroplasmy (%)

0

6,016

1

1

99.97

Patient
Blood

1

5,381

0

1

99.96

Mother blood

Urine

0

5,958

0

1

99.98

Sister blood

1

5,839

1

0

99.97

Notes. Data are the number of reads for the specific nucleotide (A, C, G, T) with G as the wild type (wt) and A as the mutant. The percentage of heteroplasmy is the ratio
of mutant/wt. The very low proportion of G, C, and T reads likely represents nonspecific sequence “noise.” The true percentage of heteroplasmy is more than 99.9% and
likely represents homoplasmy for the mutant.

3.3

|

Biochemical results

To investigate the pathogenic role of m.3697G>A and
the possible cause of the sex bias, the levels of OXPHOS
complexes were measured in immortalized lymphocytes
derived from several family individuals. Blue Native
PAGE/Immunoblot analysis revealed a significantly decreased level of OXPHOS complex I in the lymphocytes
of the male patients III3 and III5 compared with that of
the female patients II4, III6, and a control, but the other
OXPHOS complexes were not impaired (Figure 4a,b).
Consistently, the ATP production rate was significantly
decreased in the male patient III3 and III5 compared
with that of the female patient II4, III6, and a control
(Figure 4c).

3.4

|

Genomic DNA mutation

Initially, the exome NGS did not find variants in the PDE8B
gene for autosomal‐dominant striatal degeneration, or in the
SLC25A19, NUP62, ADAR1, and VAC14 genes for autosomal‐recessive BSN. In addition, no variants were found in the
NADH:Ubiquinone oxidoreductase subunit A1 (NDUFA1,
OMIM #300078) gene or in the NADH:Ubiquinone oxidoreductase subunit B11 (NDUFB11, OMIM #300403)
gene, both of which were located on the X chromosome.
Owing to the obvious female bias in the family, we carefully
compared the variants on the X chromosome between the
index patient (III3) and his sister (III4) in the exome database. The filtering strategy was followed as a hemizygote in
the index patient and a heterozygote in his sister on the X

F I G U R E 4 Blue Native PAGE blot revealed an isolated decrease of OXPHOS complex I in the male patients III3 and III5 compared with that
of the female patients II4, III6, and a control; the other OXPHOS complexes were not impaired (a,b). The ATP production rate was significantly
decreased in the male patients III3 and III5 compared with that of the female patients II4, III6, and a control (c). C: control; CI: complex I; CII:
complex II; CIII: complex III; CIV: complex IV; CV: complex V

ZHONG et al.

chromosome. We identified two candidate genes (Supporting
Information Table S2). The shroom family member 2
(SHROOM2, OMIM #300103) gene showed a missense
mutation NC_000023.11:c.1426G>C, p.(Gly476Arg) with
a low allele frequency of 0.001796 in the gnomAD database. The leucine zipper protein 4 (LUZP4, OMIM #300616)
gene had a missense mutation NM_016383.4:c.382A>G,
p.(Asn128Asp) with a low allele frequency 0.0002301 in the
gnomAD database.

4

|

D IS C U SSION

The heteroplasmic m.3697G>A mutation had been associated with MELAS (Kirby et al., 2004), LHON (Spruijt et
al., 2007), LHON/MELAS overlap syndrome (Blakely et
al., 2005), and synergetic effects for Stuve‐Wiedemann syndrome (Morava et al., 2006). In contrast, the homoplasmic
m.3697G>A mutation was only reported in a family with
LS (Negishi et al., 2014). By reviewing the literatures about
m.3697G>A mutation (Supporting Information Table S3),
we found that the patient 1 reported by Negishi and colleagues indeed presented with a phenotype of early child‐
onset BSN and relatively good prognosis (Negishi et al.,
2014), and the younger brother described by Spruijt and colleagues should be patient with early child‐onset BSN and a
stationary condition (Spruijt et al., 2007). Our patients also
presented with child‐onset spastic dystonia selectively involved in the bilateral putaminal lesions. At least eight other
variants of mtDNA could cause BSN that was characterized
by spastic dystonia (Campos et al., 1997; Solano et al., 2003).
Among those variants, the phenotype of m.14459G>A mutation showed a great similarity with that of m.3697G>A.
The patients with m.14459G>A mutation also presented with
LHON, dystonia, and LS/Leigh‐like syndrome (LLS) (Kim,
Ki, & Park, 2010; Ronchi et al., 2011). Indeed, optic atrophy,
childhood‐onset dystonia, BSN, LLS, and LS can be considered as a phenotypic spectrum of severity likely determined
by the mutational heteroplasmy (Gropman et al., 2004).
The nomenclature of BSN is based on neuroradiological
alterations, especially the degeneration of bilateral putamen,
globus pallidus, and caudate nucleus. Our male patients
showed bilateral putamen degeneration, except for the patient
III5 who had an additional involvement of bilateral caudate
nucleus. However, the affected female patients only presented
with unilateral putamen degeneration. The asymmetrical lesions were also observed in the LS patient with homoplasmic
m.3697G>A mutation (Negishi et al., 2014). This phenomenon suggested that the basal ganglion lesions had great
heterogeneity in patients with homoplasmic m.3697G>A
mutation. The typical phenotype of LS is a subacute progressive necrotizing encephalomyelopathy with poor prognosis
characterized by bilateral symmetric necrosis of gray matter
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nuclei in the basal ganglia, diencephalons, cerebellum, or
brainstem (Rahman et al., 1996). The radiological features
of BSN overlapped greatly with, but not identical to those
of LS. Therefore, the m.3697G>A mutation‐associated BSN,
particularly the one confined to the putamen, might be considered as an abortive pattern of LS.
The disease severity and penetrance of mitochondrial diseases have been considered the results of mutation loads. For
example, cases with m.8993T>G homoplasmy at a high mutation load caused LS, whereas lower mutation load resulted
in a less severe phenotype (Sofou et al., 2018). Similarly,
heteroplasmy of m.3697G>A might cause various mitochondrial disorders that presumably depended on the level of heteroplasmy. To our knowledge, homoplasmic mutation was
only reported to be associated with LS (Negishi et al., 2014).
In the current study, the individuals carrying homoplasmic
m.3697G>A mutation presented with highly variable phenotypes, especially more severe clinical severity in the male
patients than the females. The biochemical analysis revealed
that the mutation caused an isolated defect of complex I, but
the defect magnitude was higher in male patients than female
ones, which can be the possible reason for the most striking discrepancy of clinical phenotype between the male and
female patients. However, the underlying causes for the sex
bias should be further explored.
Patients with different ethnic groups likely have different mtDNA haplogroups, although a precise definition of
the haplotypes is available in few subjects (Qu et al., 2010).
In this family, there were 45 variants in the mitochondrial
genome, which pointed to the haplogroup D5b1b. This haplogroup had been reported to be associated with schizophrenia, Parkinson disease, and diabetes in Japanese population
(Tanaka et al., 2004). Although mitochondrial haplogroups
could influence the phenotypic presentation of BSN and LS,
no evidence could be found between m.3697G>A and haplotype D5b1b disclosed in our patients.
A double hit hypothesis of disease predicts that only
those who also inherit an X‐linked recessive phenotype
modifier will actually develop the mitochondrial disease
(Chen, Chen, & Guan, 2015). Apparently, the sex bias in
this BSN family suggested that one or more modifier genes
on the X chromosome might be responsible for the phenotypic variability and incomplete penetrance. By exome
NGS screening, we did not find any variants in the NDUFA1
and NDUFB11 genes that encode the protein subunits of
complex I on the X chromosome. We found two suspicious
genes (Shroom2 and LUZP4) that closely co‐segregated
with the phenotype in the family. Shroom2 is implicated
in amiloride‐sensitive sodium channel activity that may be
involved in endothelial cell morphology changes during
cell spreading. Depletion of this gene results in an increase
in endothelial sprouting, migration, and angiogenesis. This
gene is highly expressed in the retina and may regulate the

8 of 9
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biogenesis of melanosomes and promote their association
with the apical cell surface by inducing gamma‐tubulin redistribution, but it is supposed not to be expressed in the
brain tissue (Farber, Rizaldy, & Hildebrand, 2011). LUZP4
is an export adapter that enhances the RNA‐binding activity of the nuclear RNA export factor NXF1 and can restore mRNA export function in cells compromised by loss
of mRNA export adapters. It is highly expressed in cancer
cells, but reported not to be expressed in the brain tissue
(Viphakone et al., 2015). Therefore, the above genes were
less likely to take synergetic effects on BSN, though they
should be further investigated.
Significant sex bias had been universally described
in the LHON pedigrees, in which the male offspring
presented with more severe visual loss and higher penetrance, but the female offspring exhibited mild symptoms
and low penetrance (Hudson et al., 2005). Similarly, no
definite genetic modifiers were identified in these LHON
patients. However, studies on LHON have revealed that
estrogens could exert a potential compensatory effect on
mutant cell metabolism through lowering oxidative stress
and thus would reduce damage to the complex I proteins
and increase ATP synthesis (Giordano et al., 2011). Future
studies should be warranted to explore, yet it is uncertain
whether estrogens can exert a potential effect on the phenotype of BSN.
In summary, this study identified homoplasmic
m.3697G>A mutation as a cause of BSN and supported the
role of MTND1 as a key player in the complex I. Although
the female ancestors transmitted the BSN‐associated mtDNA
mutation to all of their offspring, most females never presented with clinical symptoms and exhibited variably reduced penetrance with a sex bias that favored in the males.
The preliminary investigations had not found the underlying
genetic modifiers to support the double hit hypothesis, while
the high level of estrogens in the female patients might exert
a potential compensatory effect on mutant cell metabolism.
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